Bgm (BGM) Goodwill & Intangibles (2019 - 2025)
Bgm (BGM) posted quarterly Goodwill & Intangibles of $355.3 million for Q3 2025, up 7727.93% year-over-year from $4.5 million in Q3 2024, and up 154.12% quarter-over-quarter from $139.8 million in Q1 2025.
Bgm (BGM) Goodwill & Intangibles (2019 - 2025) Analysis & Trends
Bgm (BGM) has reported Goodwill & Intangibles for 7 consecutive years, with $355.3 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Goodwill & Intangibles rose 7727.93% year-over-year to $355.3 million; the TTM figure through Sep 2025 stood at $355.3 million (up 7727.93% YoY), while the FY2025 annual figure was $355.3 million, up 7727.93% from the prior year.
- Goodwill & Intangibles climbed to $355.3 million in Q3 2025 per BGM's latest filing, from $139.8 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $3679.8 billion in Q1 2023 and bottomed at $1.7 million in Q3 2022.
- Historically, Goodwill & Intangibles has averaged $750.5 billion across 5 years, with a median of $72.2 million in 2024.
- Annual changes were most pronounced in 2024 — Goodwill & Intangibles plunged 100.0% — and 2025, when it soared 7727.93%.
- Bgm's Goodwill & Intangibles stood at $1.9 million in 2021, then slipped by 10.43% to $1.7 million in 2022, then jumped by 98.25% to $3.4 million in 2023, then jumped by 32.59% to $4.5 million in 2024, then jumped by 7727.93% to $355.3 million in 2025.
- Business Quant data shows BGM's Goodwill & Intangibles at $355.3 million in Q3 2025, $139.8 million in Q1 2025, and $4.5 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Bgm | 29.89 Mn | 20.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 355.34 Mn |
| Mar 31, 2025 | 139.83 Mn |
| Sep 30, 2024 | 4.54 Mn |
| Mar 31, 2024 | 3.42 Mn |
| Sep 30, 2023 | 3.42 Mn |
| Mar 31, 2023 | 3,679.79 Bn |
| Sep 30, 2022 | 1.73 Mn |
| Mar 31, 2022 | 1,899.18 Bn |
| Sep 30, 2021 | 1.93 Mn |
| Mar 31, 2021 | 1,925.97 Bn |
| Sep 30, 2020 | 1.88 Mn |
| Sep 30, 2019 | 1.83 Mn |